title: Endotoxin evaluation of eleven lipopolysaccharides by whole blood assay does not always correlate with Limulus amebocyte lysate assay.
abstract: More than 90% of all publications on endotoxin were carried out with endotoxins (lipopolysaccharide, LPS) from enterobacteriaceae. We compared the immune stimulatory potency of 11 different LPSs using human whole blood incubations. While the majority of LPSs induced cytokine release equipotently, a 1,000-fold more LPS from Pseudomonas aeruginosa or Vibrio cholerae was still less potent in inducing TNF, IL-1 beta, IL-10 and IFN-gamma though it potently induced nanogram quantities IL-8. All LPSs tested, regardless of the micro-organism, showed Toll-like receptor (TLR)4-dependence, except for the LPSs from P. aeruginosa and V. cholerae, which were both TLR4- and TLR2-dependent. Interestingly, UV-inactivated P. aeruginosa bacteria, although Gram-negative, also showed TLR2- and TLR4-dependence. Re-purification of commercial LPS preparations by phenol re-extraction led to a complete loss of the TLR2 dependency, indicating contamination with lipoproteins. In the Limulus amebocyte lysate assay, often performed to exclude contamination in purified water likely to originate from P. aeruginosa, P. aeruginosa LPS was only 2-fold less potent than LPS from S. abortus equi or the assay standard LPS from E. coli. This results in an overestimation of pyrogenic burden by a factor of 500 in the sample when compared with the biological activity of highly purified P. aeruginosa LPS in human whole blood.
authors.affiliation: Biochemical Pharmacology, University of Konstanz, Konstanz, Germany.
authors.forename: Oliver
authors.initials: O
authors.lastname: Dehus
authors.forename: Thomas
authors.initials: T
authors.lastname: Hartung
authors.forename: Corinna
authors.initials: C
authors.lastname: Hermann
mesh_terms: D000818:Animals; D001427:Bacterial Toxins / Q000633:toxicity*; D001769:Blood / Q000187:drug effects / Q000378:metabolism; D001854:Bone Marrow Cells / Q000187:drug effects / Q000276:immunology; D016207:Cytokines / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004797:Enzyme-Linked Immunosorbent Assay; D004926:Escherichia coli / Q000276:immunology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D008033:Limulus Test / Q000379:methods*; D008070:Lipopolysaccharides / Q000145:classification / Q000276:immunology / Q000633:toxicity*; D051379:Mice; D008809:Mice, Inbred C3H; D018345:Mice, Knockout; D011550:Pseudomonas aeruginosa / Q000276:immunology; D051193:Toll-Like Receptors / Q000235:genetics / Q000276:immunology / Q000378:metabolism
chemical_list: D001427:Bacterial Toxins; D016207:Cytokines; D008070:Lipopolysaccharides; D051193:Toll-Like Receptors